Search

Displaying results 6241 - 6250 of 9322 in total
  1. Drug

    Mapinastine

    go.drugbank.com/drugs/DB20076
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Mapinastine is a antihistaminic. Mapinastine has a monoisotopic molecular weight of 410.28 Da.

  2. Drug

    Palinavir

    go.drugbank.com/drugs/DB20083
    Experimental

    The usage of the INN stem '-vir' in the name indicates that Palinavir is a antiviral. Palinavir has a monoisotopic molecular weight of 708.4 Da.

  3. Drug

    Metrifudil

    go.drugbank.com/drugs/DB20226
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Metrifudil is a vasodilator. Metrifudil has a monoisotopic molecular weight of 371.16 Da.

  4. Drug

    Cloxypendyl

    go.drugbank.com/drugs/DB20322
    Experimental

    The usage of the INN stem '-pendyl' in the name indicates that Cloxypendyl is a vasodilator. Cloxypendyl has a monoisotopic molecular weight of 404.14 Da.

  5. Drug

    Bamirastine

    go.drugbank.com/drugs/DB21186
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Bamirastine is a antihistaminic. Bamirastine has a monoisotopic molecular weight of 527.29 Da.

  6. Drug

    Barmastine

    go.drugbank.com/drugs/DB21253
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Barmastine is a antihistaminic. Barmastine has a monoisotopic molecular weight of 483.24 Da.

  7. Drug

    Zanoterone

    go.drugbank.com/drugs/DB21384
    Experimental

    The usage of the INN stem '-terone' in the name indicates that Zanoterone is a antiandrogen. Zanoterone has a monoisotopic molecular weight of 416.21 Da.

  8. Drug

    Romlusevimab

    go.drugbank.com/drugs/DB16494
    Investigational

    Romlusevimab (BRII-198) was under investigation in clinical trials (NCT04479644 and NCT04691180) to treat COVID-19, focusing on its safety, tolerability, and pharmacokinetics.

  9. Drug

    Endostar

    go.drugbank.com/drugs/DB11727
    Investigational

    Endostar is under investigation for the treatment of Nasopharyngeal Carcinoma. Endostar has been investigated for the treatment of Non-small Cell Lung Cancer.

  10. Drug

    Phytic acid

    go.drugbank.com/drugs/DB14981
    Investigational

    Phytic acid is under investigation in clinical trial NCT01000233 (Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications).